BioCatalyst

DFTX — Definium Therapeutics, Inc. catalysts

2 verified catalyst event(s) for Definium Therapeutics, Inc. (ticker DFTX). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-07-01 — A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage) · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07 (month)
in 9d
ESTIMATED
 READOUT
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)
Phase 3 · Generalized Anxiety Disorder
 DFTX Definium Therapeutics, Inc. DT120 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-08 (month)
in 1mo
ESTIMATED
 READOUT
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
Phase 3 · Generalized Anxiety Disorder
 DFTX Definium Therapeutics, Inc. DT120 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.